NDC 49502-196

SEMGLEE

Insulin Glargine

SEMGLEE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Specialty L.p.. The primary component is Insulin Glargine.

• Product ID: 49502-196_2ed619e6-67e7-402e-a3bc-7cd7b81d59bf
• NDC: 49502-196
• Product Type: Human Prescription Drug
• Proprietary Name: SEMGLEE
• Generic Name: Insulin Glargine
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-08-31
• Marketing End Date: 2022-11-30
• Marketing Category: BLA / BLA
• Application Number: BLA210605
• Labeler Name: Mylan Specialty L.P.
• Substance Name: INSULIN GLARGINE
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [CS],Insulin Analog [EPC]
• NDC Exclude Flag: N

Packaging

NDC 49502-196-75

5 SYRINGE in 1 CARTON (49502-196-75) > 3 mL in 1 SYRINGE (49502-196-35)

• Marketing Start Date: 2020-08-31
• Marketing End Date: 2022-11-30
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "SEMGLEE" or generic name "Insulin Glargine"

NDC	Brand Name	Generic Name
49502-195	SEMGLEE	SEMGLEE
49502-196	SEMGLEE	SEMGLEE
0002-7715	BASAGLAR	Insulin glargine
0002-8214	BASAGLAR	Insulin glargine
0088-2220	Lantus	insulin glargine
0088-2219	Lantus Solostar	insulin glargine
0024-5869	TOUJEO	insulin glargine
0024-5871	TOUJEO Max	insulin glargine